Catalyst Biosciences’ $60 Million Sale of Complement Portfolio

Martina Bellini North America Legal Chronicle
Tagged:

Orrick advised Catalyst Biosciences, Inc. on the deal.South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. (NASDAQ: CBIO) announced the sale of its complement asset portfolio for $60…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here